| Hans-Günter Meyer-Thompson | Hepatitiden
Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial
Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial
van der Ree, Meike H et al.
The Lancet , Volume 0 , Issue 0 ,
dx.doi.org/10.1016/S0140-6736(16)31715-9
Published: 10 January 2017
Abstract
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)31715-9/fulltext